Mechanism of Ketogenic Diet-Induced Hypercholesterolemia
Washington University School of Medicine · NCT06894004
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–39 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 100
- US sites recruiting
- 1
- Study start
- February 24, 2025
- Record last updated
- March 23, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
Very-low carbohydrate ketogenic diets can dramatically increase blood cholesterol levels, particularly in normal-weight people, for reasons that are not well understood. This study will enroll normal-weight adults, will identify "responders" who develop high cholesterol on a ketogenic diet, and will measure rates of production and removal of certain types of cholesterol-carrying particles called lipoproteins in responders. The results will clarify the mechanism by which a ketogenic diet can cause high cholesterol in certain susceptible people.
Being studied: Ketogenic Diet; Control Diet
Conditions: Hypercholesterolemia and Hyperlipidemia
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- age ≥ 18 and \< 40 years
- BMI ≥ 18.5 and \< 25.0 kg/m2
- baseline serum LDL-c \< 150 mg/dL (\< 3.9 mmol/L)
- baseline serum TG \< 100 mg/dL (\< 1.1 mmol/L)
- HbA1c ≤ 5.6%.
Exclusion Criteria
- personal or family history of familial hypercholesterolemia
- current use of lipid-lowering drugs
- currently on a ketogenic diet and unwilling to change diet
- current tobacco use
- hypertension
- prediabetes or diabetes
- elevated Lp(a) > 6.5% of ApoB-containing lipoproteins at baseline
- oral contraceptive use
- contraindication to heparin
- known atherosclerotic cardiovascular disease
- unwilling to abstain from alcohol
Recruiting US locations
Washington University School of Medicine
St Louis, MO 63110
Site contact: Nikki Plassmeyer, M.A., R.D.N., L.D. · (314) 362-0590 · nikkip@wustl.edu
Study contacts (from the official record)
- Frannie Wilkinson, M.A. · (314) 362-0590 · francesw@wustl.edu
- Max C Petersen, M.D., Ph.D. · 314-362-8352 · max.p@wustl.edu
Similar studies in Missouri
All heart & blood pressure studies in Missouri →- RecruitingHealthy volunteersPhase 1
Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HTX-001
Haya Therapeutics, Inc.
- Location
- Kansas City, MO + 1 other US site
- Eligibility basics
- Ages 18–70
- RecruitingHealthy volunteersEarly Phase 1
PET Imaging of Natriuretic Peptide Receptor C (NPR-C) in Carotid Atherosclerosis With 64Cu-NODAGA-CANF (Volunteer - Dosimetry Study)
Washington University School of Medicine
- Location
- St Louis, MO
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteersPhase 1
Liver Adiposity Effects on Pediatric Statin
Children's Mercy Hospital Kansas City
- Location
- Kansas City, MO
- Eligibility basics
- Ages 8–21
- RecruitingHealthy volunteersPhase 1
PET Detection of CCR2 in Human Atherosclerosis
Washington University School of Medicine
- Location
- St Louis, MO
- Eligibility basics
- Ages 18–89